A collaborative model for endpoint development for acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia

Clin Infect Dis. 2012 Oct;55(8):1122-3. doi: 10.1093/cid/cis567. Epub 2012 Jun 28.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Clinical Trials as Topic / methods*
  • Community-Acquired Infections / drug therapy*
  • Endpoint Determination / methods*
  • Humans
  • Pneumonia, Bacterial / drug therapy*
  • Skin Diseases, Bacterial / drug therapy*

Substances

  • Anti-Bacterial Agents